New hope for deadly septic shock: trial tests alternative treatment
NCT ID NCT06746753
Summary
This study compares two treatments for septic shock, a life-threatening condition with high mortality. Researchers will test whether giving Angiotensin II works better than the standard treatment (norepinephrine) at stabilizing patients. The trial will also look for better ways to predict how severe a patient's septic shock will become. Results could help doctors choose more effective treatments and improve survival.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPTIC SHOCK are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Atrium Health Wake Forest Baptist
Winston-Salem, North Carolina, 27157, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Massachusetts General Hospital-Harvard
Boston, Massachusetts, 02114, United States
Contact Email: •••••@•••••
Contact
Contact
Contact
Contact Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.